Type 2 diabetes mellitus may be complicated with chronic complications including diabetic
neuropathy (DN). Timely diagnosis is crucial in treatment and maybe reversal of this …

Aims/hypothesis Emerging evidence suggests that in addition to hyperglycaemia,
dyslipidaemia could represent a contributing pathogenetic factor to diabetic neuropathy …

The endogenous metabolite methylglyoxal (MG) accumulates in diabetic patients with
neuropathic pain. Methylglyoxal could be a mediator of diabetes-induced neuropathic pain …

Aims In this cross-sectional study, we explored the utility of corneal confocal microscopy
(CCM) measures for detecting diabetic polyneuropathy (DPN) and their association with …

Pediatric neuropathy attributed to metabolic dysfunction is a well‐known complication in
children and youth with type 1 diabetes. Moreover, the rise of obesity and in particular of …

Aims/hypothesis We aimed to examine associations of cardiometabolic risk factors, and
(pre) diabetes, with (sensorimotor) peripheral nerve function. Methods In 2401 adults (aged …

OBJECTIVE To assess the contemporaneous prevalence of diabetic peripheral neuropathy
(DPN) in people with type 1 diabetes (T1D) in Scotland and study its cross-sectional …

Abstract Purpose of Review Diabetic neuropathy is a debilitating complication of diabetes
mellitus that affects millions of individuals worldwide. It is characterized by nerve damage …

Background Diabetic peripheral neuropathy (DPN) is a common complication of diabetes.
Predicting the risk of developing DPN is important for clinical decision-making and …

Background Individuals with diabetes and lower-limb complications are at high risk for
cardiovascular and all-cause mortality, but uncertainties remain in terms of cancer-related …